Study Group: HemoSense PT/INR Testing Sytem Users(?)
Council Members in this Study Group: 21
Request a survey with this Study Group
Leading Experts in this Study Group
Director of Pathology
Bellevue Hospital Center
Robert Boorstein, MD, PhD, is the Director of Pathology at Bellevue Hospital and an Associate Professor in the Department of Pathology at New York University School of Medicine. He is also the Medical Director for Pathology and Laboratory Medicine of the South Manhattan Healthcare Network and Northern...
Medical Director
Icon Central Laboratories, Inc.
Joseph Schappert, MD, is the Medical Director at ICON Laboratories, Inc. in New York. He is involved in innovative and state-of-art information technology, flow cytometric and molecular diagnostic solutions in support of clinical trials conducted worldwide. Previously, Dr. Schappert was the Vice Chair...
Cardiologist
NYU Medical Center
Daniel Fisher, MD, FACC, FACP, is a Cardiologist at NYU Medical Center. He has a private practice in Cardiology and specializes in non-invasive cardiology. Dr. Fisher is board certified in Internal Medicine, Cardiovascular Diseases, and Nuclear Cardiology. He has lectured frequently on such topics as...
Jeffrey Ballard, MD, FACSVascular Surgeon
St.joseph Hospital of Orange Inc.
Jeffrey Ballard, MD, FACS, is a Vascular and Endovascular Surgeon who practices at St. Joseph Hospital of Orange, California. He also has a appointment as Clinical Professor of Surgery at University of California, Irvine. Dr. Ballard offers comprehensive care for all problems of arterial and venous...
Taral Patel, MDOncologist
Mid Ohio Oncology Hematology Inc.
Taral Patel, MD, is an Oncologist in private practice with Mid Ohio Oncology-Hematology, Inc. He treats patients with both cancer and blood disorders. Dr. Patel has been a principal investigator for multiple clinical trials in colon cancer, lung cancer, lymphoma, and growth factor. He has been on the...
Related Study Groups
| Study Group Name | Members |
|---|---|
| Physicians who Treat Arrhythmia (US) | 287 |
| Physicians who Treat Hypertension (US) | 724 |
| Heart Failure Specialists (US) | 892 |
| Physicians who Treat Hypercholesterolemia in the U.S. | 250 |
| Non-Electrophysiologist Cardiologists (US) | 846 |
| General Cardiologists (US) | 1327 |
| Oncologists (US) | 2251 |
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
It is well known that the addition of thiazide diuretic to ACEI or ARB treatment adds about 10 mm Hg reduction on top of the 10 mm Hg reduction provided by the ACEI or ARB agent. It is expected that blocking renin in the renin angiotensin system with Tekturna would provide a similar result.
Diagnostic tools are availible to identify these adverse effects at an early stage in their clinical development. These tools should mitigate the seriousness of these adverse events.
New data with low and high dose of Avastin with Taxoter
esults showed that PROVENGE patients experienced improved survival if they received more cells across the three doses of PROVENGE (higher cumulative TNC count (p=0.019)) or higher cumulative CD54 upregulation values (p=0.009). The effect on survival for TNCs appeared to reflect in part the patients'...
TRITON-TIMI 38 study of 13,608 patients with ACS compared prasugrel against clopidogrel, combined with aspirin. Prasugrel reduced the combined rate of CV death, MI or stroke (12.1% for clopidogrel vs. 9.9% for prasugrel). The benefit came at a cost of increased serious bleeding (1.4%, vs....
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Non-Academic Community Hospital or Clinic
- Office Based Private Practice or Clinic
- Contract Research Organization, Large
Most Common Job Types:
- Physician - Attending Physician
- Physician - Director
- Research Scientist
- Director
- Physician - Division Head
- Owner
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms